The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion / Hosam Mohamed Samy Mohamed ; Supervised Hany Hassan Mostafa , Shamel Mostafa Hefny , Mohamed shehata Abdallah
Material type: TextLanguage: English Publication details: Cairo : Hosam Mohamed Samy Mohamed , 2015Description: 148 P. : charts ; 25cmOther title:- دور الاستخدام الوقائى للجرعات المنخفضة من الأسبرين و الكالهيبارين لمرضى الإجهاض المتكرر غير مفسر السبب [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.15.Ph.D.2015.Ho.R (Browse shelf(Opens below)) | Not for loan | 01010110067808000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.15.Ph.D.2015.Ho.R (Browse shelf(Opens below)) | 67808.CD | Not for loan | 01020110067808000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics
In contrast to sporadic miscarriage, recurrent miscarriage is relatively uncommon, a history of three or more consecutive miscarriages occurs in 0.5 - 2 percent of women. Approximately 1 to 2 percent of women of reproductive age will experience three or more spontaneous consecutive miscarriages. Recurrent miscarriage is a heterogeneous condition, the pathogenesis of which is multifactorial, complex and poorly understood. In order to provide successful treatment, a thorough understanding of possible reasons for miscarriage and an extensive diagnostic work-up to evaluate associated conditions is required. Recently the use of thromboprophylaxis and aspocid is suggested to patients with recurrent unexplained abortion. In our study 50 patients with recurrent abortion were classified into two groups one of them on calheparin and aspocid and the other on no treatment and data was collected according to fate of each group
Issued also as CD
There are no comments on this title.